AIDS RESEARCH AND HUMAN RETROVIRUSES

AIDS RESEARCH AND HUMAN RETROVIRUSES Journal

publication venue for

An Open-Label Pharmacokinetic and Pharmacodynamic Assessment of Tenofovir Gel and Oral Emtricitabine/Tenofovir Disoproxil Fumarate 2021
The Effect of Hormonal Contraception on Cervicovaginal Mucosal End Points Associated with HIV Acquisition. 35:1-12. 2019
The Effect of Hormonal Contraception on Cervicovaginal Mucosal End Points Associated with HIV Acquisition. 35:853-864. 2019
A Longitudinal Assessment of Cervical Inflammation and Immunity Associated with HIV-1 Infection, Hormonal Contraception, and Pregnancy. 34:889-899. 2018
Comparison of Mucosal Markers of Human Immunodeficiency Virus Susceptibility in Healthy Premenopausal Versus Postmenopausal Women. 33:807-819. 2017
Analytical Advances in the Ex Vivo Challenge Efficacy Assay. 33:395-403. 2017
Comparison of Follicular and Luteal Phase Mucosal Markers of HIV Susceptibility in Healthy Women. 32:547-560. 2016
Biomarkers of Cervical Inflammation and Immunity Associated with Cervical Shedding of HIV-1. 32:443-451. 2016
A Pilot Study Measuring the Distribution and Permeability of a Vaginal HIV Microbicide Gel Vehicle Using Magnetic Resonance Imaging, Single Photon Emission Computed Tomography/Computed Tomography, and a Radiolabeled Small Molecule. 31:1109-1115. 2015
Bacterial Vaginosis and Subclinical Markers of Genital Tract Inflammation and Mucosal Immunity. 31:1139-1152. 2015
Increased Expression of CD169 on Blood Monocytes and Its Regulation by Virus and CD8 T Cells in Macaque Models of HIV Infection and AIDS. 31:696-706. 2015
Toward Early Safety Alert Endpoints: Exploring Biomarkers Suggestive of Microbicide Failure. 29:1475-1486. 2013
Depot Medroxyprogesterone Acetate Increases Immune Cell Numbers and Activation Markers in Human Vaginal Mucosal Tissues. 29:592-601. 2013
Pharmacokinetics and Topical Vaginal Effects of Two Tenofovir Gels in Rabbits. 28:1458-1466. 2012
In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials. 21:845-853. 2005
Anti-HIV Activity and Drug Concentrations in Tenofovir-based Products: Intravaginal Ring Versus Oral Tablet 2018
Effect of Hormonal Contraception on Pharmacokinetics of Vaginal Tenofovir: Increased Tenofovir Diphosphate in Depot Medroxyprogesterone Acetate Users 2018
Estrogen, Progesterone and Sex-hormone Binding Globulin in Association With Innate Immunity Correlates of HIV Risk and Protection 2018
HIV Prevention in Healthy Women: Safety and Pharmacokinetics of a Potential New Tenofovir Alafenamide Fumarate (TAF)-based Oral PrEP Regimen 2018
Testing Objective Markers of Placebo Vaginal Product Adherence in the Field 2018
Using Photovoice to Understand the Experience and Realities of Female Sex Workers in the Context of HIV Self-testing in Blantyre, Malawi 2018
Vaginal Microbiota and Mucosal Pharmacokinetics of Tenofovir in Healthy Women Using Placebo, Tenofovir and Tenofovir/Levonorgestrel Vaginal Rings 2018
Can Infrared Spectroscopy (IR) Coupled with Chemometrics Be Used for Objective Measure of Adherence to Microbicide Products? 2016
Clinical Assessment of New Objective Measures of Adherence for Four Placebo Vaginal Dosage Platforms 2016
Clinical Performance, Acceptability, and Optimization of Fast-dissolve Vaginal Inserts Designed for HIV-prevention: Results from Two Clinical Studies 2016
Correlation of Residual Microbicide Levels with Objective Biomarker Analysis to Determine Adherence in a Large Phase III HIV Prevention Trial 2016
Development and Proof-of-Concept Clinical Evaluation of a Freeze-dried Topical Microbicide Insert for On-demand HIV Prevention 2016
Development of Long-acting Nanoparticle-based Formulations for Prolonged Intravaginal Delivery of Elvitegravir 2016
Epithelial Barrier Alteration and Increased HIV Target Cells Coexist in Inflamed Human Cervices: A Biological Pathway to Enhanced HIV Susceptibility? 2016
Long-acting Intrauterine System Delivers Integrase Inhibitor Throughout the Reproductive Tract of Rabbits and Macaques 2016
Pharmacokinetics/Pharmacodynamics of Tenofovir and Tenofovir Plus Levonorgestrel Vaginal Rings in Women 2016
The Role of Vitamin D on Genital Mucosal Immunity and Markers of HIV Susceptibility in Women 2016
Time of Addition Studies of Elvitegravir/TFV Prodrug Combinations Demonstrate Extended Window of Prophylactic Activity in Cell and Tissue Models 2016
Use of Injectable Depot Medroxyprogesterone Acetate (DMPA) Downregulates Vaginal Epithelial Barrier Genes - Similarly to Mucosal Inflammation 2016
Assessment of the Vaginal Residence Time of Biomarkers of Semen Exposure 2014
Effect of Bacterial Vaginosis on Markers of Genital Tract Inflammation and Mucosal Immunity: Mechanisms for Susceptibility to HIV Infection 2014
Gene Expression Analysis of Human Vaginal Mucosal Response to Pro-inflammatory Stimuli - Identification of Biomarkers of Vaginal Inflammation 2014
Humic Acids (HA) Strongly Potentiate Anti-HIV Effects of AZT, Griffithsin, and Cyanovirin 2014
Mucosal Susceptibility to HIV-1 and Tenofovir Protection in Explanted Cervicovaginal Tissues from Postmenopausal Compared to Premenopausal Women 2014
Multicompartmental Pharmacokinetics of Tenofovir 1% Gel Using the BAT 24 Regimen Versus Daily and Single Pericoital Dosing 2014
Obstetric and Infant Outcomes Following Planned Maternal Third Trimester Exposure to Tenofovir 1% Vaginal Gel 2014
Population Pharmacokinetic Model of Vaginal Tenofovir 1% Gel in the Cervicovaginal Fluid 2014
Tenofovir Gel Acceptability and Adherence among Pregnant Women in the United States 2014
Site-Specific Phosphorylation Regulates Human T-Cell Leukemia Virus Type 2 Rex Function In Vivo 2009
HTLV-1 tax disrupts the cellular DNA damage response via binding and sequestration of active DNA-PK 2007

category

IMMUNOLOGY Web of Science Category
INFECTIOUS DISEASES Web of Science Category
VIROLOGY Web of Science Category

International Standard Serial Number (ISSN)

0889-2229

Electronic International Standard Serial Number (EISSN)

1931-8405

journal abbreviation

AIDS RES HUM RETROV